Home
Conditions
Intestinal Neoplasms

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,348 public trials 1,367 recruiting studies

Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Recruiting

Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps

NCT06807073

Conditions: Colonic Diseases, Colonic Polyps, Colorectal Cancer, +15 more
Locations: Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada

View Trial Details

Recruiting

Image-Guided Surgery In The Treatment Of Rectal Cancer (AR_CRC)

NCT06805045

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Genomic Investigation of Unusual Responders

NCT03740503

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +49 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

NCT06793137

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: A.C Camargo Cancer Center São Paulo, Brazil

View Trial Details

Recruiting

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

NCT06620627

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer Screening, +10 more
Locations: Natera Austin, Texas, United States

View Trial Details

Recruiting

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

NCT03526835

Conditions: Advanced/Metastatic Solid Tumors, Carcinoma, Carcinoma, Squamous Cell, +26 more
Locations: UCSD La Jolla, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Sharp Healthcare San Diego, California, United States

Rocky Mountain Cancer Centers Lone Tree, Colorado, United States

View all 45 locations

View Trial Details

Recruiting

Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal Cancer

NCT06799793

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer

NCT06522919

Conditions: Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +11 more
Locations: IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l. Meldola, Forlì Cesena, Italy

Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card.G.Panico" Tricase, Lecce, Italy

View Trial Details

Recruiting

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

NCT05517811

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Biliary Cancer, +34 more
Locations: University of Colorado Denver Aurora, Colorado, United States

View Trial Details

Recruiting

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

NCT06643793

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +9 more
Locations: Affiliated Hospital Of Nantong University Nanjing, Jiangsu, China

View Trial Details

Intestinal Neoplasms

Intestinal Neoplasms trial results

Related conditions